EMIM 2017 in Cologne
Thank you for coming to see Cubresa’s NuPET™ at the EMIM 2017 Meeting & Exhibition in Cologne Reveal disease & therapeutic mechanisms with simultaneous molecular & functional imaging This year’s European Molecular Imaging Meeting at Hörsaalgebäude University in Cologne, April 5 to 7, 2017 was a very successful showcase for our NuPET™ in-bore PET scanner for existing pre-clinical MRI systems. The…
Cubresa SPECT Scanner Used for Evaluation of Alzheimer’s Disease Molecular Label in vivo
Cubresa’s SPECT scanner was used to determine if a novel molecular label, TRV6001, in development for in vivo imaging of the BChE enzyme present in the brains of Alzheimer’s Disease patients follows the known distribution of the enzyme in animal models of the disease. Winnipeg, MB – November 22, 2016 – Cubresa Inc., a medical…
Webinar: Greater than the Sum
Simultaneous imaging with complementary modalities: PET & MRI If you missed our free webinar on Thursday, November 10th, you can request a link to view the recording, where you can learn how PET and MRI complement each other, and how one customer, Dr. Marty Pagel of the University of Arizona, is developing a dual-modality approach…
Cubresa Moves to Larger Facility in Winnipeg
Cubresa’s new, larger headquarters will open for business at the following address on Tuesday September 6, 2016: Cubresa Inc. 801 Berry Street Winnipeg, MB R3H 0S7 Our telephone and facsimile numbers, as well as our e-mail addresses and web address, will remain the same. We look forward to fully utilizing our improved headquarters for research &…
Preclinical PET Scanner for Simultaneous PET/MRI Installed at the University of Arizona Could Contribute to Improved Tumor Assessment
Dual-modality approach being developed by the University of Arizona uses Cubresa’s NuPET™ PET scanner and a dynamic MRI technique to more fully characterize cancerous tumors. Winnipeg, MB – September 1, 2016 – Cubresa Inc., a medical imaging company that develops and markets molecular imaging systems, today announced the successful installation of their compact PET scanner called NuPET™ for…
BIOTIC and Cubresa continue successful partnership with PET scanner testing
Halifax, NS – August 5, 2016 – BIOTIC (Biomedical Translational Imaging Centre), the advanced imaging center at the IWK Health Centre, has been chosen as the first research facility to test a new preclinical PET (Positron Emission Tomography) scanner. Cubresa, a medical imaging company that develops and markets nuclear imaging systems, has developed NuPET™, a…
Cubresa Booth 207 at WMIC in New York
Cubresa to Exhibit at the WMIC 2016 Annual Congress & Exhibition in New York UPDATE: Congratulations to Patrick Chow of Bristol-Myers Squibb, on winning our custom-engraved Apple® iPad™ Pro in the booth on Saturday. Dr. Chow was selected at random from attendees who participated in our survey. Bookmark this page[1]To bookmark this page, press the Ctrl (PCs)…
Imaging cloak patent could enable more accurate 3D medical imaging
Winnipeg, MB – July 13, 2016 – Instead of a cloak of invisibility hiding a person in television and movies, a new method that describes mounting many imaging sensors underneath a flexible substrate could reveal tumors within humans or animals. Cubresa Inc., a medical imaging company that develops and markets nuclear imaging systems, today announced…
Preclinical PET Scanner for Simultaneous PET/MRI Adds to Cancer Research Arsenal at the University of Arizona
Cubresa’s NuPET™ scanner enables simultaneous preclinical molecular & functional imaging. The PET (Positron Emission Tomography) scanner inserts into existing MRI (Magnetic Resonance Imaging) systems and can speed drug development and clarify disease mechanisms for biomedical researchers. Cancer researchers can better understand tumors using Cubresa’s NuPET™ PET scanner with an MRI to see and measure responses…
Cubresa is a world leader in the design and development of clinical and preclinical PET inserts for MRI. Cubresa products enable medical professionals at leading universities, hospitals and pharmaceutical companies to visualize and measure biochemical processes at the molecular level.
Company
About Us
Leadership
Technology
Careers
Location
Cubresa Inc.
800-136 Market Ave
Winnipeg, MB, Canada
R3B 0P4
Products
Clinical:
Preclinical:
Contact
Request more information